Investor Relations

Latest Event

Cancer AI Symposium

Latest Financial Results

Q2 2024

Quarter Ended Jun 30, 2024

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2023

Company Overview

BullFrog AI, an emerging digital biopharma company, is committed to changing that paradigm.

Using our proprietary AI/ML analytics platform, we aim to improve drug development and clinical trials through identification of high-value data niches and patient subgroups. This will ultimately lead to improved clinical outcomes for patients, and reduction of trial-and-error treatment strategies in our disease areas of focus.

Our mission is to improve lives by identifying critical connections between therapies and highly responsive patients – in less time, with less cost, and more precision.

Stock Snapshot

IR Contacts

Headquarters

BullFrog AI Holdings, Inc.
325 Ellington Blvd.
#317
Gaithesburg, MD 20878
T: 240-658-6710
info@bullfrogai.com

Investor Relations

RedChip Companies Inc.
Rob Foley
VP Investor Relations
431 E Horatio Ave
Suite #100
Maitland, FL 32751
T: 1-800-RED-CHIP (733-2447)
Rob@redchip.com

Transfer Agent

VStock Transfer, LLC
18 Lafayette Place
Woodmere, NY 11598
T: 212-828-8436
F: 646-536-3179
0-K@vstocktransfer.com